Our research is focused on: 1. Identifying genetic markers for chemotherapy induced adverse drug reactions 2. the toxicity of new psychoactive substances & how to use post-mortem metabolomics. We develop prediction models using massive parallel sequencing, single cell RNASeq & high resolution chromatin conformation capture and bioinformatics with large clinical cohorts. In forensics, we develop new techniques using the CBRS platform for neuropharmacology as well as post-mortem metabolomics.
Henrik Green
Linköping University
Key Publications
In vitro human hepatocyte incubation of 5F-MDMB-PINACA, 5F-MDMB-PICA, 5F-EMDB-PICA, 4F-MDMB-BICA, and 4F-MDMB-BINACA and cannabinoid receptor 1 activity profiling of major human metabolites
Archives of Toxicology, 2026
Untargeted metabolomics reveals a reproducible signature associated with fatal insulin intoxication
Scientific Reports, 2026
Comprehensive in vitro profiling of traditional and emerging stimulants at monoamine transporters and the 5‐HT2A receptor
British Journal of Pharmacology, 2026
Postmortem metabolomics as a window into the agonal phase of death: a comparison between opioid intoxications and hangings
International Journal of Legal Medicine, 2026
Anomaly detection as a tool for identifying cases of interest in postmortem toxicology
Scientific Reports, 2026